Genpharm
FDA Approved Drugs

Genpharm

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 12
  • Latest Approval Date Jul 09, 2007
  • Data Source FDA
  • First Approval Date Aug 19, 1997
Company Overview

Company

Genpharm

Country

U.A.E

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Genpharm

Business Bay, Al Manara Tower, Office 2805

U.A.E

www.genpharmservices.com/ View on Map
FDA Approved Drug Records ( 12 records )
1997
19 Aug
Discontinued Application: 73045

Drug Name

ALBUTEROL

Product Number

1

Dosage Form

-

Strength

0.09MG/INH

Approval Date

1997-08-19

73045 / 1

Active Ingredient

ALBUTEROL

Application Number

73045

Product Number

1

Dosage Form

-

Strength

0.09MG/INH

Approval Date

1997-08-19

Regulatory Status

Discontinued

2007
09 Jul
Discontinued Application: 77362

Drug Name

AMLODIPINE BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2007-07-09

77362 / 1

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77362

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2007-07-09

Regulatory Status

Discontinued

2007
09 Jul
Discontinued Application: 77362

Drug Name

AMLODIPINE BESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-07-09

77362 / 2

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77362

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-07-09

Regulatory Status

Discontinued

2007
09 Jul
Discontinued Application: 77362

Drug Name

AMLODIPINE BESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-07-09

77362 / 3

Active Ingredient

AMLODIPINE BESYLATE

Application Number

77362

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-07-09

Regulatory Status

Discontinued

2004
11 Feb
Discontinued Application: 76476

Drug Name

BENAZEPRIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2004-02-11

76476 / 1

Active Ingredient

BENAZEPRIL HYDROCHLORIDE

Application Number

76476

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2004-02-11

Regulatory Status

Discontinued

2004
11 Feb
Discontinued Application: 76476

Drug Name

BENAZEPRIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2004-02-11

76476 / 2

Active Ingredient

BENAZEPRIL HYDROCHLORIDE

Application Number

76476

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2004-02-11

Regulatory Status

Discontinued

2004
11 Feb
Discontinued Application: 76476

Drug Name

BENAZEPRIL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2004-02-11

76476 / 3

Active Ingredient

BENAZEPRIL HYDROCHLORIDE

Application Number

76476

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2004-02-11

Regulatory Status

Discontinued

2004
11 Feb
Discontinued Application: 76476

Drug Name

BENAZEPRIL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2004-02-11

76476 / 4

Active Ingredient

BENAZEPRIL HYDROCHLORIDE

Application Number

76476

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2004-02-11

Regulatory Status

Discontinued

2000
18 Oct
Discontinued Application: 75466

Drug Name

DOXAZOSIN MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2000-10-18

75466 / 1

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75466

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2000-10-18

Regulatory Status

Discontinued

2000
18 Oct
Discontinued Application: 75466

Drug Name

DOXAZOSIN MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2000-10-18

75466 / 2

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75466

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2000-10-18

Regulatory Status

Discontinued

2000
18 Oct
Discontinued Application: 75466

Drug Name

DOXAZOSIN MESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2000-10-18

75466 / 3

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75466

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2000-10-18

Regulatory Status

Discontinued

2000
18 Oct
Discontinued Application: 75466

Drug Name

DOXAZOSIN MESYLATE

Product Number

4

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2000-10-18

75466 / 4

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75466

Product Number

4

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2000-10-18

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    12 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALBUTEROL

Application Number

73045

Product Number

1

Active Ingredient

ALBUTEROL

Dosage Form

-

Strength

0.09MG/INH

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.